Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorJaeb Center for Health Research

About this trial

This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF.

The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.

Eligibility criteria

Qualifiers

Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative

For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes)

Be willing and able to adhere to the study protocol requirements

Age ≥ 12 years at time of enrollment

Disqualifiers

History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject

History of transplant

Pregnancy reported by participant at time of consent or at any point during active study participation

Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias

Trial design

Treatments tested in this trial

  • observational study

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

Jaeb Center for Health Research

Lead sponsor

Cystic Fibrosis Foundation

Collaborator